SCHEMBL8159338

SCHEMBL8159338

CCC/C(=C/C=O)c1cc(C(C)(C)C)cc(C(C)(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
BLM P54132 1/20 0.37
CASP7 P55210 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
RXRA P19793 8/20 0.36
RXRB P28702 8/20 0.36
RXRG P48443 7/20 0.36
RARA P10276 1/20 0.36
RARB P10826 1/20 0.36
RARG P13631 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
HMGCR P04035 1/20 0.35
HDAC8 Q9BY41 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8159340 1.00 TP53 (0.37) TP53CYP3A4MAPTALOX15MAPK1
SCHEMBL7773472 0.82 GABRA1 (0.40) TP53CYP3A4MAPTALOX15MAPK1
SCHEMBL6553921 0.78 GABRA1 (0.36) TP53CYP3A4MAPTALOX15MAPK1
SCHEMBL8146556 0.75 RXRA (0.68) RXRARXRBRXRGRARARARB
SCHEMBL8851049 0.75 RXRA (0.68) RXRARXRBRXRGRARARARB
SCHEMBL8153962 0.75 RXRA (0.68) RXRARXRBRXRGRARARARB
SCHEMBL8159678 0.75 RXRA (0.68) RXRARXRBRXRGRARARARB
SCHEMBL8850282 0.75 RXRA (0.68) RXRARXRBRXRGRARARARB
SCHEMBL8154607 0.73 RXRA (0.43) TP53CYP3A4MAPTALOX15MAPK1
SCHEMBL8160160 0.73 RXRA (0.55) TP53CYP3A4MAPTALOX15MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6083977-A HAVING ACTIVITY FOR RETINOIC ACID RECEPTORS AND RETINOID X RECEPTORS LIGAND PHARMACEUTICALS INCORPORATED (US) 2000-07-04 US disclosed
EP-0800503-B1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2000-05-10 EP disclosed
US-5721103-A SKIN DISORDERS; VISION DEFECTS LIGAND PHARMACEUTICALS INCORPORATED (US) 1998-02-24 US disclosed
EP-0800503-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 1997-10-15 EP disclosed
WO-1996020913-A1 NOVEL TRIENOIC RETINOID COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 1996-07-11 WO disclosed